Microbial Antigen-Presenting Extracellular Vesicles Derived from Genetically Modified Tumor Cells Promote Antitumor Activity of Dendritic Cells.

导出 OA

翻译打印收藏纠错

作者： Tomoko,Ito ^[1] ; Kikuya,Sugiura ^[2] ; Aya,Hasegawa ^[3] ; Wakana,Ouchi ^[4] ; Takayuki,Yoshimoto ^[2] ; Izuru,Mizoguchi ^[2] ; Toshio,Inaba ^[2] ; Katsuyuki,Hamada ^[3] ; Masazumi,Eriguchi ^[3] ; Yoshiyuki,Koyama ^[2]

作者单位： Japan Anti-Tuberculosis Association, Shin-Yamanote Hospital, Tokyo 189-0021, Japan. ^[1] Department of Advanced Pathobiology, Graduate School of Life and Environmental Sciences, Osaka Prefecture University, Osaka 598-8531, Japan. ^[2] Department of Immunoregulation, Institute of Medical Science, Tokyo Medical University, Tokyo 160-8402, Japan. ^[3] Department of Clinical Oncology, School of Medicine, Toho University, Tokyo 143-8541, Japan. ^[4]

关键词 ESAT-6 cancer immunotherapy dendritic cells extracellular vesicles neoantigens

DOI 10.3390/pharmaceutics13010057

PMID 33406722

发布时间 2021-02-18

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交